NewslettersImmune Regulation NewsPulmonary Cell News Jagged2 Targeting in Lung Cancer Activates Anti-Tumor Immunity via Notch-Induced Functional Reprogramming of Tumor-Associated Macrophages By Noshin Noorjahan - April 24, 2024 0 The authors studied the role of the Notch ligand Jagged2 on immune evasion in NSCLC. Higher expression of JAG2 in NSCLC negatively correlated with survival. [Immunity] AbstractPress ReleaseGraphical Abstract